Literature DB >> 17674309

Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons.

Vitaliano A Cama1, Jennifer M Ross, Sara Crawford, Vivian Kawai, Raul Chavez-Valdez, Daniel Vargas, Aldo Vivar, Eduardo Ticona, Marco Navincopa, John Williamson, Ynes Ortega, Robert H Gilman, Caryn Bern, Lihua Xiao.   

Abstract

We performed a cross-sectional study to determine the epidemiology of Cryptosporidium in human immunodeficiency virus (HIV)-infected persons at 3 diagnostic levels: microscopy, genotypes of Cryptosporidium, and subtype families of C. hominis and C. parvum. The study enrolled 2,490 HIV-infected persons in Lima, Peru, and 230 were microscopy positive for Cryptosporidium infection. Specimens from 193 participants were available for genotyping. They had C. hominis (141 persons), C. parvum (22 persons), C. meleagridis (17 persons), C. canis (6 persons), C. felis (6 persons), and C. suis (1 person) infection. Although microscopy results showed that Cryptosporidium infections were associated with diarrhea, only infections with C. canis, C. felis, and subtype family Id of C. hominis were associated with diarrhea, and infection with C. parvum was associated with chronic diarrhea and vomiting. These results demonstrate that different Cryptosporidium genotypes and subtype families are linked to different clinical manifestations.

Entities:  

Mesh:

Year:  2007        PMID: 17674309     DOI: 10.1086/519842

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  75 in total

Review 1.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

2.  Evaluation of four commercial rapid immunochromatographic assays for detection of Cryptosporidium antigens in stool samples: a blind multicenter trial.

Authors:  Patrice Agnamey; Claudine Sarfati; Claudine Pinel; Meja Rabodoniriina; Nathalie Kapel; Emmanuel Dutoit; Cécile Garnaud; Momar Diouf; Jean-François Garin; Anne Totet; F Derouin
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

3.  Occurrence, source, and human infection potential of cryptosporidium and Giardia spp. in source and tap water in shanghai, china.

Authors:  Yaoyu Feng; Xukun Zhao; Jiaxu Chen; Wei Jin; Xiaonong Zhou; Na Li; Lin Wang; Lihua Xiao
Journal:  Appl Environ Microbiol       Date:  2011-04-15       Impact factor: 4.792

4.  Occurrence of Giardia intestinalis and Cryptosporidium sp. in wastewater samples from São Paulo State, Brazil, and Lima, Peru.

Authors:  Francisco Miroslav Ulloa-Stanojlović; Bruna Aguiar; Luis M Jara; Maria Inês Zanoli Sato; Juana Arzola Guerrero; Elayse Hachich; Glavur Rogério Matté; Milena Dropa; Maria Helena Matté; Ronalda Silva de Araújo
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-09       Impact factor: 4.223

5.  Cryptosporidium meleagridis: infectivity in healthy adult volunteers.

Authors:  Cynthia L Chappell; Pablo C Okhuysen; Rebecca C Langer-Curry; Donna E Akiyoshi; Giovanni Widmer; Saul Tzipori
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

6.  Cryptosporidium infection in children with cancer undergoing chemotherapy: how important is the prevention of opportunistic parasitic infections in patients with malignancies?

Authors:  Reza Berahmat; Mahmoud Mahami-Oskouei; Azim Rezamand; Adel Spotin; Nayyereh Aminisani; Roghayeh Ghoyounchi; Solmaz Madadi
Journal:  Parasitol Res       Date:  2017-07-20       Impact factor: 2.289

7.  Identification of a high diversity of Cryptosporidium species genotypes and subtypes in a pediatric population in Nigeria.

Authors:  Síle F Molloy; Huw V Smith; Patrick Kirwan; Rosely A B Nichols; Samuel O Asaolu; Lisa Connelly; Celia V Holland
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

8.  Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Authors:  Michael Imboden; Michael W Riggs; Deborah A Schaefer; E Jane Homan; Robert D Bremel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

Review 9.  Burden of disease from cryptosporidiosis.

Authors:  Debbie-Ann T Shirley; Shannon N Moonah; Karen L Kotloff
Journal:  Curr Opin Infect Dis       Date:  2012-10       Impact factor: 4.915

10.  Cryptosporidium species and subtypes and clinical manifestations in children, Peru.

Authors:  Vitaliano A Cama; Caryn Bern; Jacqueline Roberts; Lilia Cabrera; Charles R Sterling; Ynes Ortega; Robert H Gilman; Lihua Xiao
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.